MAM
XLRN

Melqart Asset Management’s Acceleron Pharma XLRN Stock Holding History

Melqart Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-82,000
Closed -$14.1M – 117
2021
Q3 		$14.1M Buy
+82,000
New +$10.7M 0.68% 38

Melqart Asset Management's XLRN Position: Q4 2021 in Review

Melqart Asset Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 82,000 shares — an estimated $14.1M sold.

Melqart Asset Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $14.1M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Melqart Asset Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Melqart Asset Management sold 82,000 Acceleron Pharma shares in Q4 2021, an estimated $14.1M.
  • Melqart Asset Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • Melqart Asset Management's Acceleron Pharma position peaked at $14.1M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Melqart Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.